This paper examines the implications for risk-rated insurance when patients of Australian general practitioners are having genetic testing, highlighting the risk of genetic discrimination.

An update on the genetic basis of sudden cardiac death (SCD) in the young and the clinical aspects of caring for families affected by SCD.

General practitioners can incorporate pharmacogenomic testing into their clinical practice and improve many prescribing decisions for their patients.

An update on the various treatment methods available today to tackle pilonidal disease.

The majority of infants born at <32 weeks of gestation display normal neurodevelopment in early childhood. Regular follow-up is essential for early identification of neurodevelopmental morbidity.

This review examines the anatomy of the pupillary pathway and provides a structured approach to examination of the pupils.

Undescended testis is a common condition; management in a timely fashion may reduce the risk of malignancy and infertility.

Risk-taking behaviours in adolescents are rarely detected in clinical practice without deliberate assessment within a youth-friendly framework.

To prevent heat-related disease, GPs need to work across prevention levels to mitigate climate change, recognise vulnerable patients, and work with these patients to plan management strategies.

It is critical to identify the physical health needs of people with severe mental illnesses, develop engagement strategies and tailor interventions to the person’s specific circumstances.

This paper summarises the updated recommendations from the National Health and Medical Research Council pertaining to colorectal cancer screening so that they may be applied in general practice.

Black salve is promoted as an effective, safe and natural skin cancer treatment, but such claims are not evidence-based, and serious complications have been reported.

Prescribing drugs to reduce the risk of cancer is a new development in primary cancer prevention.

Late-preterm infants are at an increased risk of neurodevelopmental abnormalities in early childhood, compared with full-term infants.

The symptom burden and care needs for patients with end-stage, non-malignant illnesses are similar to those of patients with advanced cancer.